Cox regression analysis
| . | OS . | EFS . | PFS . | DFS . | ||||
|---|---|---|---|---|---|---|---|---|
| Parameter | HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P |
| Including PCR* (n = 60) | ||||||||
| Lack of molecular remission | ND | ND | 4.09 (1.73-9.70) | .001 | 3.06 (1.24-7.55) | .015 | 4.3 (1.61-11.50) | .004 |
| B symptoms | ND | ND | — | — | 2.43 (1.01-5.85) | .047 | — | — |
| Excluding PCR* (n = 134) | ||||||||
| ECOG performance status ≥ 2 | 2.82 (1.06-7.49) | .038 | — | — | — | — | — | — |
| Lack of CR/CRu | 6.32 (2.80-14.23) | < .001 | — | — | — | — | — | — |
| R-HDS arm | — | — | 0.36 (0.22-0.60) | < .001 | 0.30 (0.17-0.53) | < .001 | 0.37 (0.18-0.78) | .009 |
| B symptoms | — | — | 1.67 (1.03-2.70) | .038 | — | — | — | — |
| . | OS . | EFS . | PFS . | DFS . | ||||
|---|---|---|---|---|---|---|---|---|
| Parameter | HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P |
| Including PCR* (n = 60) | ||||||||
| Lack of molecular remission | ND | ND | 4.09 (1.73-9.70) | .001 | 3.06 (1.24-7.55) | .015 | 4.3 (1.61-11.50) | .004 |
| B symptoms | ND | ND | — | — | 2.43 (1.01-5.85) | .047 | — | — |
| Excluding PCR* (n = 134) | ||||||||
| ECOG performance status ≥ 2 | 2.82 (1.06-7.49) | .038 | — | — | — | — | — | — |
| Lack of CR/CRu | 6.32 (2.80-14.23) | < .001 | — | — | — | — | — | — |
| R-HDS arm | — | — | 0.36 (0.22-0.60) | < .001 | 0.30 (0.17-0.53) | < .001 | 0.37 (0.18-0.78) | .009 |
| B symptoms | — | — | 1.67 (1.03-2.70) | .038 | — | — | — | — |
ND indicates not done due to the low number of events; and —, not significant.
Only significant variables were included.